MTIM
HZNP

Marathon Trading Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Marathon Trading Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-47,820
Closed -$5.14M – 366
2023
Q2 		$4.92M Buy
+47,820
New +$5.05M 0.41% 46
2021
Q1 		– Sell
-13,200
Closed -$966K – 545
2020
Q4 		$966K Buy
+13,200
New +$981K 0.05% 159

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Marathon Trading Investment Management's HZNP Position: Q3 2023 in Review

Marathon Trading Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 47,820 shares — an estimated $5.14M sold.

Marathon Trading Investment Management first reported a position in HZNP in Q4 2020 and held it in 2 quarters. The position peaked at $4.92M in Q2 2023. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

  • Marathon Trading Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Marathon Trading Investment Management sold 47,820 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $5.14M.
  • Marathon Trading Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 2 quarters.
  • Marathon Trading Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.92M in Q2 2023.
  • 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Marathon Trading Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.